ALB and metabolic dysfunction-associated steatohepatitis: However, liver-related mortality was significantly higher in patients with NASH compared to non-NASH counterparts (17.5% vs. 2.7%; P=0.0048), as well as in diabetics, elderly patients, and those with reduced albumin at baseline [13].